The trademark Biolex was filed by Leiber GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on January 31, 2005, and received undefined oppositions.
There are undefined Oppositions claimed against trademark.
The first opposition filed on April 29, 2005 by Alltech, Inc. on (a) Identity of marks and Goods and Services, (b) Likelihood of confusion, (c) Unfair advantage and detriment to distinctiveness or repute, (d) Earlier non registered TM & right to prohibit use of later TM under national law, (e) Earlier sign & right to prohibit use of later TM under national law. the opponent was represented by MARKS & CLERK LLP and its proceedings were handled in English The second opposition filed on April 15, 2005 by SENSIENT FLAVORS BIOLUX S.A. on Likelihood of confusion. the opponent was represented by NOVAGRAAF BELGIUM S.A./N.V. and its proceedings were handled in English
The application was filed in German, and German was also language of all opposition proceedings (English was selected as the second language).
The renewal of the trademark was recorded by the office on December 11, 2013.
Change of name and professional address of the trademark registration was recorded on August 20, 2007. Change of name and professional address of the trademark registration was recorded on March 1, 2010. Relative errors of the trademark registration was recorded on April 24, 2014. Change of name and professional address of the trademark registration was recorded on April 22, 2015.
The Appeal with reference B R0406/2007-2 was Opposition partially rejected according to Article 8(1)(b) CTMR with decision issued on February 19, 2008 by the EUIPO. The Opposition with reference B 000827255 was partially refused EUTMA/IR according to Article 8(1)(b) CTMR with decision issued on February 5, 2007 by the EUIPO.
The application claimed as seniority of the Federal Republic of Germany trademark 301 43 012.8/01 registered on April 4, 2002 and filed on July 17, 2001 which was accepted by the office.